Albumin News and Research

RSS

New study finds gaps in treatment for patients with chronic kidney disease

Millions of Canadians living with chronic kidney disease (CKD) may be going without critical testing from their primary care practitioners that would give them a good idea of the severity of the disease so they could intervene earlier with more appropriate care, according to a new study.

24 Oct 2019

FUJIFILM Irvine Scientific receives CE Mark approval for innovative ART products

FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the receipt of CE Mark approval for key ART products.

From FUJIFILM Irvine Scientific 8 Oct 2019

New test to establish integrity of biosamples used in medical research

Effective diagnosis and treatment of disease draws on painstaking research, which often relies on biological samples.

23 Sep 2019

New biomarkers help predict response to treatment in common brain tumor

Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.

16 Sep 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence

A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, “Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?”

27 Aug 2019

Placing students at the heart of Albumedix

Albumedix employ two postgraduates through the University of Nottingham placements scheme with companies for 3-6 months for up to 200 hours.

From Albumedix Ltd. 20 Aug 2019

Albumedix announces evaluation agreement with a top pharma collaborator

Novartis and Albumedix Ltd. have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis technology platform and associated technologies.

From Albumedix Ltd. 20 Aug 2019

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, can be detected by medical imaging and has staying power in the bloodstream.

19 Aug 2019

Molecular mechanism of enterovirus infection uncovered

Researchers from the Nanoscience Center at the University of Jyväskylä in collaboration with those at the University of Helsinki have found that body proteins called albumin and certain ions within the attacked host cells can affect the genetic workings of enteroviruses and enhance their infection.

19 Aug 2019

Research reveals physiological events leading to successful enterovirus infection

Enteroviruses are one of the most common human pathogens leading to high number of acute and chronic infections worldwide.

19 Aug 2019

Liver function may be important in Alzheimer’s disease risk

A new study shows a strong link between altered liver function and the development of Alzheimer’s disease (AD). This correlates with recent data on the role played by diseases affecting the systemic metabolism, such as diabetes and high blood cholesterol, in disruptions of brain function as in AD.

31 Jul 2019

EKF to showcase Lucica Glycated Albumin-L test for diabetes patient monitoring at AACC 2019

EKF Diagnostics, announces the availability of a liquid, enzymatic test for glycated albumin that was recently FDA cleared for sales in the U.S.

From EKF Diagnostics 26 Jul 2019

New color-changing tattoos can monitor glucose levels and other metabolites in real-time

Scientists in Germany have developed an intradermal tattoo that changes color in response to fluctuations in glucose, albumin, and pH levels.

23 Jul 2019

Dermal tattoo biosensors for detecting metabolites and blood pH change

The art of tattooing may have found a diagnostic twist. A team of scientists in Germany have developed permanent dermal sensors that can be applied as artistic tattoos.

18 Jul 2019

New drug-delivery system disguises chemotherapeutics as fat to outsmart tumors

A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors.

18 Jul 2019

Promising method delivers drug to cancer cells without affecting surrounding cells

RIKEN researchers have developed a promising method to deliver a drug to cancer cells without affecting surrounding tissues, involving a clever combination of an "artificial metalloenzyme" that protects a metal catalyst, and a sugar chain that guides the metalloenzyme to the desired cells.

2 Jul 2019

Doctors urge hospitals to reconsider the type of fluids used to treat children with sepsis

Doctors have urged hospitals around the world to reconsider the type of fluids used to treat children gravely ill with sepsis.

11 Jun 2019

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

22 Apr 2019

Study offers new hope for patients with decompensated cirrhosis

Decompensated cirrhosis is a chronic disease linked to numerous complications in its final stage. Professor Jonel Trebicka from Goethe University was involved in carrying out a pilot study demonstrating that the long-term administration of albumin in high doses stabilizes the circulatory function of these patients and protects them from sepsis.

4 Apr 2019

Albumin News and Research

New study finds gaps in treatment for patients with chronic kidney disease

FUJIFILM Irvine Scientific receives CE Mark approval for innovative ART products

New test to establish integrity of biosamples used in medical research

New biomarkers help predict response to treatment in common brain tumor

How much control is too much in type 1 diabetes?

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence

Placing students at the heart of Albumedix

Albumedix announces evaluation agreement with a top pharma collaborator

Chemists develop new approach based on graphene nanoflakes for drug delivery

Molecular mechanism of enterovirus infection uncovered

Research reveals physiological events leading to successful enterovirus infection

Liver function may be important in Alzheimer’s disease risk

EKF to showcase Lucica Glycated Albumin-L test for diabetes patient monitoring at AACC 2019

New color-changing tattoos can monitor glucose levels and other metabolites in real-time

Dermal tattoo biosensors for detecting metabolites and blood pH change

New drug-delivery system disguises chemotherapeutics as fat to outsmart tumors

Promising method delivers drug to cancer cells without affecting surrounding cells

Doctors urge hospitals to reconsider the type of fluids used to treat children with sepsis

Study provides new insight into how obesity, insulin resistance can affect cognition

Study offers new hope for patients with decompensated cirrhosis

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News